InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,159.73
(
0.62%
)
US TECH 100
17,535.60
(
0.67%
)
Dow Jones
38,767.53
(
0.24%
)
Brent Oil
83.05
(
-0.10%
)
Bitcoin
63,380.42
(
-0.96%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: None

Wednesday, 12/18/2019 8:25:43 AM

Wednesday, December 18, 2019 8:25:43 AM

Post# of 30990
A thought occurred to me last night regarding the future availability of Anatabloc. As we know, MYMD Pharmaceuticals is working to establish isomyosmine as a new immunometabolic regulator. Should they be successful and license this technology to others, the licensee would surely insist that Anatabloc not be available as an over the counter competitor.

Thoughts anyone?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up